All articles tagged with #price cuts
Target beat earnings expectations in Q2 as sales rose across all departments, traffic improved, and margins benefited from tariff refunds; the retailer raised full-year guidance and signaled ongoing price investments amid a broad merchandising reset, with CEO Michael Fiddelke saying the turnaround is gaining traction and aims for years of sustained top-line growth.
Trump claimed Walmart would lower prices at his administration’s request, but Walmart said the price cuts were planned independently of the White House; as that narrative unraveled, the White House denounced the media for an “obsessive” tendency to undermine good news about the president.
CNBC’s Q2 Housing Market Survey shows more agents (44%) report a balanced market, up from 30% a year earlier, signaling buyers and sellers are regaining leverage amid higher supply and easing prices. Price cuts dropped (57% vs 89%), but prices remain about 1% higher YoY; June asking prices fell 2.5% YoY. Contract cancellations declined to 40%. Mortgage rates fluctuated, with the 30-year fixed peaking near 6.75% in May and hovering around 6.6% since, while inventory rose to about 1.1 million listings. Overall optimism wanes: 19% expect sales to improve, 67% expect them to stay the same, with significant local variation and a push toward hyper-local data.
With Prime Day over, lingering discounts keep the Galaxy S26 line and Pixel 10 series discounted: the S26 Ultra starts under $1,000 (256GB) with a $200 upgrade to 512GB, the S26+ and S26 follow with savings across storage options, the S25 FE remains cheaper but less competitive, and Pixel 10 Pro/XL are about $300 off while Pixel 10 and 10a offer mid-range savings; compare these against the Galaxy S25 FE and S26 to gauge value.
Novo Nordisk will cut Wegovy by 50% and Ozempic by 35% starting January 2027, setting a $675 per-month price for both drugs and for Rybelsus as well, as it faces competition from Lilly’s Mounjaro/Zepbound and other GLP-1 therapies; the company says the cuts aim to lower out-of-pocket costs for patients with high-deductible plans, and direct-to-patient discounts will remain unchanged.
Novo Nordisk warned profits and sales could fall as much as 13% due to unprecedented price pressure on GLP-1 weight‑loss drugs, amplified by a U.S. government price deal. The news sparked an about 18% drop in the stock as the company grapples with competition from Eli Lilly, patent expiries, and ongoing cost-cutting, with CEO Maziar Doustdar saying the cuts are painful but intended to broaden access and drive future growth.
PepsiCo will cut the suggested US retail prices of snacks like Doritos, Lay's and Cheetos by nearly 15% this week in response to consumer pressure over higher living costs and the appetite-suppressing GLP-1 medications; packaging, ingredients and taste will stay the same, while retailers set shelf prices. The move, timed before the Super Bowl, aims to boost demand as the company focuses on multipacks, portion control and upcoming health-oriented products such as Doritos Protein, while pursuing productivity savings for 2026.
Home buyers in the US are benefiting from record-level price reductions, with the typical listing seeing around $25,000 in cuts in October, especially in expensive markets like Los Angeles and New York, as the housing market rebalances and homes take longer to sell.
The US housing market is diverging into two distinct regions: the Sun Belt and Mountain West are experiencing falling prices and increased inventory due to reduced migration and demand, while the Midwest and Northeast remain strong with tight inventories and rising prices, reflecting broader shifts in migration, labor market, and affordability trends post-pandemic.
Tesla has introduced lower-priced Model Y and Model 3 variants by removing premium features and reducing costs, aiming to boost sales volume despite squeezing profit margins. The move is part of a strategy to increase market share amid rising competition and declining regulatory credits, but analysts remain cautious about the impact on Tesla's profitability.
In August, new-home sales in the U.S. surged by 20.5% to a three-year high, driven by builder discounts and lower mortgage rates, despite some economist skepticism about the sustainability of this spike. The median price of new homes increased slightly, and the sales increase was most notable in the Northeast, indicating a potential rebound in housing activity amid improved affordability.
BYD's stock has plummeted over 30%, losing $45 billion in value amid investor concerns over its aggressive discounting strategy to compete with domestic and U.S. rivals, coupled with disappointing quarterly results and a reduced vehicle delivery forecast, raising questions about its long-term growth prospects.
McDonald's is reducing prices on some combo meals to attract customers and counteract declining visits due to high costs, potentially sparking a broader fast food price war as rivals may follow suit amid industry-wide traffic drops and rising operational costs.
U.S. homebuilder sentiment has unexpectedly declined to its lowest level since December 2022, influenced by high mortgage rates and economic uncertainty, leading builders to use price cuts and incentives to attract buyers. Despite some easing in mortgage rates, the housing market remains challenged, with low sales expectations and depressed construction activity.
Homebuilders are reducing prices at the highest rate in three years due to weakening demand and affordability issues, despite slight improvements in builder confidence driven by recent tax relief measures. The NAHB index remains below 50, indicating negative sentiment, with 38% of builders cutting prices and buyer traffic at a two-year low, signaling ongoing challenges in the housing market.